In the European Journal of Clinical Investigation, Jeffrey Gulcher and Kári Stefánsson have a written debate with David Ransohoff and Muin Khoury. Gulcher and Stefánsson argue that as variants associated with disease are found, they should be made available to patients, without a physician intermediary.